Article Information
History
- September 8, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Prabin Dahal1,2,*,
- Sauman Singh-Phulgenda1,2,
- Caitlin Naylor1,2,
- Matthew Brack1,2,
- Mitali Chatterjee3,
- Fabiana Alves4,
- Philippe J Guerin1,2 and
- Kasia Stepniewska1,2
- 1Infectious Diseases Data Observatory (IDDO), Oxford, UK
- 2Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
- 3Institute of Postgraduate Medical Education & Research (IPGMER), Kolkata, India
- 4Drugs for Neglected Diseases initiative, Geneva, Switzerland
- ↵*Correspondence to:
Dr. Prabin Dahal, New Richards Building, Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Email: prabin.dahal{at}iddo.org Tel: +44 01856 612 900
Posted September 08, 2023.
Design, conduct, analysis, and reporting of therapeutic efficacy studies in Visceral Leishmaniasis: A systematic review of published reports, 2000-2021
